AEON Biopharma, Inc. (AEON) Dividend History

Company News

• AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

  AEON Biopharma, a clinical-stage biopharmaceutical company, announced the closing of a $20 million public offering. The company plans to use the proceeds for general corporate purposes and working capital.

  Benzinga
• AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

  AEON Biopharma, a clinical-stage biopharmaceutical company, announced a public offering of shares and warrants to raise funds for general corporate and working capital needs.

  GlobeNewswire Inc.
• Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

  Match Group shares jumped 8% in pre-market trading after Starboard Value took a stake of over 6.5% in the company and is advocating for a potential sale. Several other stocks also saw significant pre-market movement.

  Benzinga

  Featured Companies: AMIX AREB CDT CHGG DATS DJT GRNQ MTCH OPEN QLGN UAVS WNW
• Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround

  AEON Biopharma, Inc. (AEON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

  Zacks Investment Research
• AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

  AEON Biopharma, Inc. (AEON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

  Zacks Investment Research